The Association Between Fibrosis-4 Index and All-Cause and Cardiac Mortality in Patients With Coronary Heart Disease

Chenxi Song1,2, Zhihao Zheng1,2, Xiaohui Bian1,2

  • 1Department of Cardiology Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Medcomm
|June 8, 2026
PubMed

Insights

The fibrosis-4 index (FIB-4) score, a noninvasive liver fibrosis marker, is linked to increased all-cause and cardiac mortality risks in patients with diabetes/prediabetes and cardiovascular disease.

Area of Science:

  • Cardiology
  • Hepatology
  • Metabolic Diseases

Background:

  • Cardiovascular disease (CVD) and diabetes/prediabetes are significant risk factors for mortality.
  • Liver fibrosis, identified by the fibrosis-4 index (FIB-4), is increasingly recognized as a potential contributor to systemic health risks.
  • The association between FIB-4 and mortality in patients with both CVD and diabetes/prediabetes is not well-established.

Purpose of the Study:

  • To investigate the impact of the fibrosis-4 index (FIB-4) on all-cause and cardiac mortality.
  • To evaluate FIB-4's prognostic value in a high-risk population with diabetes or prediabetes and confirmed cardiovascular disease.

Main Methods:

  • Analysis of two large patient cohorts: Fuwai Hospital (N=20,133) and UK Biobank (N=5678).
  • Utilized multivariable Cox regression analysis to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).
  • Adjusted for multiple confounding factors including glucose levels, age, sex, and body mass index.

Main Results:

  • Elevated FIB-4 scores were significantly associated with increased hazards of all-cause mortality in both cohorts (Fuwai: HR 2.58; UKB: HR 1.26).
  • Elevated FIB-4 scores were also significantly associated with increased hazards of cardiac mortality in both cohorts (Fuwai: HR 2.99; UKB: HR 1.41).
  • These associations remained consistent across various subgroups, including different glucose levels, age, sex, and BMI.

Conclusions:

  • Liver fibrosis, as indicated by FIB-4, is a significant predictor of elevated all-cause and cardiac mortality.
  • FIB-4 assessment should be considered for risk stratification in patients with coronary heart disease and co-existing diabetes or prediabetes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...